The second phase of the current study consisted of the quantitative analysis of pools of CD45+ leukocytes and CD326+ CTCs in various groups of patients with HNSCC and counting the subpopulations of these pools containing the studied ABPs. Here, EPCAM is linked to head and neck squamous cell carcinoma.